Health And Pharma

Pan-Cancer Analysis: ALK Mutation May Help Identify Tumors More Likely to Respond to Immunotherapy

A pan-cancer analysis of 2,930 patients across 11 tumor types found that ALK mutation was associated with significantly ...
ascopubs.org

Swiss-PO 2025: Advancing Cancer Mutation and Structural Analysis for Precision Oncology With the Latest Release

Impact of Germline BRCA Mutation Status on Antitumor Activity of Modified FOLFIRINOX in Patients With Advanced Pancreatic Cancer: An Exploratory Analysis Swiss-PO was expanded and redesigned to ...
ascopubs.org

Analysis of genetic mutation profile and CNS pharmacokinetics in relapsed/refractory primary CNS lymphoma patients responding to novel emavusertib (IRAK4i) and BTKi combination.

Phase 2 study of nivolumab for patients with meningiomas refractory to surgery and radiotherapy with immune-related response criteria. This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...
EurekAlert!

Integrative scATAC-seq and mtDNA mutation analysis reveals disease-driven regulatory aberrations in AML

Disruptions in transcriptional regulation during hematopoiesis can lead to abnormal hematopoietic differentiation and the development of leukemia. Understanding the underlying mechanisms of disease ...